In LKR13 wild-type (WT)-inoculated mice, miRNA treatment inhibited tumor burden, and in PD-L1 knockdown LKR13-inoculated mice the effect of miRNA treatment was minimal (Figure 5E). The gene discussed is CD274; the disease is neoplasm.